Many pharma and biotech companies today have either not digitized their production processes or only to a certain extent. If production data is available electronically at all, it is hardly contextualized, so that it can only be used insufficiently to increase production performance, quality or compliance. In most cases, it is challenging to setup upfront clear, reliable and executable digital production IT strategies, where all necessary aspects in terms of people, processes, data and technology are carefully considered, planned and put into a context to drive production IT compliance and excellence.
The new Principal Consulting & Client Advisory services help drug manufacturers to develop and implement holistic digital manufacturing IT strategies utilizing the broad PAS-X MES portfolio of Werum Solutions, that is tailor-made to the customer’s circumstances and business targets. Customers will be advised and supported throughout the entire digitization lifecycle, from the very beginning of the digital strategic analysis and definition process to project/program execution up to optimization potentials in operations. The new unit is headed by Zinaid Dzinovic, who worked for several years at a major pharma and biotech manufacturer in Switzerland in various positions.
“Turning pains into gains: with our new PAS-X MES Consulting & Advisory services we address our customers’ key pain points in business, quality, compliance and operational excellence,” says Zinaid Dzinovic, Director of Principal Consulting & Client Advisory Software, Körber Business Area Pharma. “The new services are complementing our existing portfolio and help our customers in the strategic process towards fully digitizing their pharma operations.”
Torsten Isenberg, Vice President Global Business Consulting Software, Körber Business Area Pharma, adds: “In discussions with our customers, we often find that the organizations are only insufficiently prepared for the digital transformation. We want to ensure an understanding for the disruptive potential of digitization. Together with our customers we develop and implement the right strategy for the successful journey to their digital pharma 4.0 factory of the future.”
